Today’s gene therapies are often given via systemic delivery methods.
We are pioneering research into intrathecally-delivered gene therapies intended to target the heart and skeletal muscle. Through this platform, we are exploring how to develop potentially safe and effective gene therapies.
Learn how we are pioneering the development of intrathecally-delivered gene therapies.
© 2026 Insmed Incorporated. All Rights Reserved.